Scientific Case Studies

Designing T-cell engagers to widen the therapeutic window

Functional and specific T-cell engagers for a peptide-MHC tumor target

Discovery of diverse GPCR-targeted antibodies

Diverse CD28-binding antibodies for costimulatory T-cell engager development

Development of PSMA x CD3 T-cell engagers using an integrated, functional approach

Antibody candidates ready for IND-enabling studies

Presentations & Posters

Presenting at SITC 2024: Applications of AbCellera’s T-cell engager platform

Presented at AACR 2024: Expanding the reach of T-cell engagers

Presented at SITC 2023: Streamlining T-cell engager development

Presented at AACR 2023: AbCellera’s T-cell engager platform

Presented at SITC 2022: CD3 T-cell engagers that strike the right balance

Presented at AACR 2022: CD3-binding antibodies for T-cell engager discovery

August 27, 2024

Developability considerations for bispecific and multispecific antibodies

February 14, 2023

Potent transmission-blocking monoclonal antibodies from naturally exposed individuals target a conserved epitope on Plasmodium falciparum Pfs230

February 14, 2023

Highly potent, naturally acquired human monoclonal antibodies against Pfs48/45 block Plasmodium falciparum transmission to mosquitoes